FDG imaging of spinal cord primitive neuroectodermal tumor.
PET with 18F-fluoro-2-deoxy-glucose (FDG) is well established as an effective imaging modality for evaluating suspected brain tumor recurrence. Use of FDG PET imaging for spinal cord neoplasms has not yet been studied, in large part due to limitations of spatial resolution. One report of FDG PET imaging of brain involvement with primitive neuroectodermal tumor (PNET) demonstrated mild hypometabolism relative to cortical gray matter. We demonstrate with FDG PET imaging the appearance of recurrent intramedullary PNET affecting the cervical spinal cord.
Meltzer
C C
CC
Department of Radiology, University of Pittsburgh Medical Center, Pennsylvania 15213-2582, USA.
Townsend
D W
DW
Kottapally
S
S
Jadali
F
F
D000328:Adult; D005240:Feasibility Studies; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging*; D018242:Neuroectodermal Tumors, Primitive / Q000000981:diagnostic imaging*; D019275:Radiopharmaceuticals; D013120:Spinal Cord Neoplasms / Q000000981:diagnostic imaging*; D014055:Tomography, Emission-Computed
D005462:Fluorine Radioisotopes; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18